| 000 | 01010 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513015026.0 | ||
| 264 | 0 | _c19810915 | |
| 008 | 198109s 0 0 eng d | ||
| 022 | _a0065-2229 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRecasens, M | |
| 245 | 0 | 0 |
_aAn alternate CSA pathway regulating taurine metabolism? _h[electronic resource] |
| 260 |
_bAdvances in biochemical psychopharmacology _c1981 |
||
| 300 |
_a545-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xmetabolism |
| 650 | 0 | 4 |
_aCentral Nervous System _xmetabolism |
| 650 | 0 | 4 |
_aCysteine _xanalogs & derivatives |
| 650 | 0 | 4 | _aImmunochemistry |
| 650 | 0 | 4 | _aIsoenzymes |
| 650 | 0 | 4 | _aNeurotransmitter Agents |
| 650 | 0 | 4 |
_aSulfinic Acids _xmetabolism |
| 650 | 0 | 4 |
_aTaurine _xmetabolism |
| 650 | 0 | 4 |
_aTransaminases _xmetabolism |
| 700 | 1 | _aBenezra, R | |
| 773 | 0 |
_tAdvances in biochemical psychopharmacology _gvol. 29 _gp. 545-50 |
|
| 999 |
_c7257461 _d7257461 |
||